Public-registry site landscape for NCT04786873, a Growth Hormone Deficiency study sponsored by AEterna Zentaris. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04786873 (registry record) |
| Sponsor | AEterna Zentaris |
| Condition(s) | Growth Hormone Deficiency |
| Phase | PHASE3 |
| Listed sites | 45 |
| Site countries | United States, Armenia, Georgia, Germany, Italy, Poland, Romania, Serbia, Slovakia, Slovenia, Turkey (Türkiye) |
Eichor generates a preliminary site-risk snapshot for NCT04786873 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →